Amy Rosen to Antidepressive Agents
This is a "connection" page, showing publications Amy Rosen has written about Antidepressive Agents.
Connection Strength
0.171
-
Charbonneau A, Parker V, Meterko M, Rosen AK, Kader B, Owen RR, Ash AS, Whittle J, Berlowitz DR. The relationship of system-level quality improvement with quality of depression care. Am J Manag Care. 2004 Nov; 10(11 Pt 2):846-51.
Score: 0.054
-
Charbonneau A, Rosen AK, Owen RR, Spiro A, Ash AS, Miller DR, Kazis L, Kader B, Cunningham F, Berlowitz DR. Monitoring depression care: in search of an accurate quality indicator. Med Care. 2004 Jun; 42(6):522-31.
Score: 0.053
-
Charbonneau A, Rosen AK, Ash AS, Owen RR, Kader B, Spiro A, Hankin C, Herz LR, Jo V Pugh M, Kazis L, Miller DR, Berlowitz DR. Measuring the quality of depression care in a large integrated health system. Med Care. 2003 May; 41(5):669-80.
Score: 0.049
-
Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005 Dec 15; 119(1-3):5-15.
Score: 0.015